Arix Bioscience Holdings Ltd 4
4 · Harpoon Therapeutics, Inc. · Filed May 29, 2020
Insider Transaction Report
Form 4
Arix Bioscience plc
10% Owner
Transactions
- Sale
Common stock
2020-05-28$21.33/sh−366,591$7,820,926→ 2,193,704 total(indirect: See Footnote) - Sale
Common stock
2020-05-27$22.39/sh−12,064$270,144→ 2,560,295 total(indirect: See Footnote)
Footnotes (3)
- [F1]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $22.00 to $24.00 per share, inclusive. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission (the "SEC"), the Issuer, or a security holder of the Issuer.
- [F2]These shares are owned directly by Arix Bioscience Holdings Limited, which is a wholly owned subsidiary of Arix Bioscience Plc. Arix Bioscience Plc is an indirect beneficial owner of the reported securities and disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
- [F3]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $21.25 to $22.00 per share, inclusive. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.